New ‘liquid biopsy’ will act as an early warning sign to anticipate risk of tumours returning
A new blood test can predict the risk of breast cancer returning three years before any tumours show up on scans in an “incredibly exciting” breakthrough that could help more women beat the disease for good.
More than 2 million women are diagnosed every year with breast cancer, the most prevalent type of the disease. Although treatment has improved in recent decades, the cancer often returns, and if it does, it is usually at a more advanced stage.
About Author
More Stories
Bankrupt DNA testing firm 23andMe to be purchased for $256m
Sea level rise will cause ‘catastrophic inland migration’, scientists warn
Bees face new threats from wars, street lights and microplastics, scientists warn